The development of thyrotoxicosis (Graves' disease) during immunosuppression for autoimmune haemolytic anaemia
- 1 August 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 112 (4) , 531-535
- https://doi.org/10.1530/acta.0.1120531
Abstract
A patient is described who developed thyrotoxicosis (Graves'' disease) during immunosuppressive therapy for acquired autoimmune haemolytic anaemia. The fact that the two conditions may be associated should be recognised. Long-term immunosuppressive therapy does not prevent the development of immunoglobulins of IgG type postulated to be aetiologically involved in Graves'' disease.This publication has 8 references indexed in Scilit:
- Coincidence of Adrenal Atrophy, Haemolytic Anaemia and Hyperthyroidism in a Patient Followed by Sudden DeathActa Medica Scandinavica, 2009
- EVIDENCE THAT THYROID-STIMULATING ANTIBODY IS PRODUCED IN THE THYROID GLANDThe Lancet, 1984
- Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.BMJ, 1984
- PREDICTION OF RELAPSE IN HYPERTHYROID GRAVES' DISEASEThe Lancet, 1980
- Association of Hyperthyroidism with Idiopathic Thrombocytopenic Purpura and Haemolytic AnaemiaActa Medica Scandinavica, 1979
- THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEYClinical Endocrinology, 1977
- REMISSION OF HYPERTHYROIDISM (GRAVES' DISEASE) AND ALTERED PATTERN OF SERUM-THYROXINE BINDING INDUCED BY PREDNISONEThe Lancet, 1965
- Thyrotoxicosis Occurring in Two Patients on Prolonged High Doses of SteroidsNew England Journal of Medicine, 1964